Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

CBP β Inhibitors

CBP β inhibitors are a class of chemical compounds specifically designed to target and modulate the activity of the CBP β protein, a variant of the CREB-binding protein (CBP) family. CBP proteins are multifunctional coactivators involved in the regulation of gene expression, where they play critical roles in modulating transcription by interacting with various transcription factors and components of the transcriptional machinery. CBP β, in particular, is thought to be involved in the regulation of genes that are responsive to cellular signaling pathways, including those that govern cell growth, differentiation, and other essential cellular processes. Inhibitors of CBP β are developed to disrupt the protein's ability to interact with transcription factors or its enzymatic activities, thereby modulating its role in gene regulation and affecting downstream cellular functions.

The development of CBP β inhibitors involves a detailed understanding of the protein's structure and its interaction with other molecular components within the cell. Structural biology techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance (NMR) spectroscopy are employed to elucidate the three-dimensional configuration of CBP β, revealing the specific domains and binding sites that are crucial for its function. This structural information is critical for identifying potential targets within the protein that can be blocked by small molecules. Computational tools, including molecular docking and virtual screening, are used to identify candidate compounds that can bind with high affinity to these sites, effectively inhibiting the protein's activity. Once potential inhibitors are identified, they are synthesized and subjected to a series of biochemical assays to evaluate their binding properties, specificity, and inhibitory potency. Through iterative cycles of optimization, including modifications to the chemical structure to enhance binding affinity and selectivity, these inhibitors are refined for increased efficacy. The study of CBP β inhibitors provides valuable insights into the role of CBP β in gene regulation and helps to elucidate the broader mechanisms by which transcriptional coactivators influence cellular processes and gene expression.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Zinc

7440-66-6sc-213177
100 g
$48.00
(0)

Essential for enzymatic functions, modulates DNA-binding proteins, potentially influencing CBP β.

Fisetin

528-48-3sc-276440
sc-276440A
sc-276440B
sc-276440C
sc-276440D
50 mg
100 mg
500 mg
1 g
100 g
$52.00
$79.00
$104.00
$156.00
$2913.00
7
(1)

A flavonoid, modulates signaling pathways involved in cellular senescence, potentially impacting CBP β.

3,4-Dihydroxyphenyl Ethanol

10597-60-1sc-202887
10 mg
$112.00
6
(1)

A phenol from olives, modulates oxidative stress and cell signaling, potentially impacting CBP β.

Gingerol

23513-14-6sc-201519
sc-201519A
5 mg
20 mg
$109.00
$387.00
5
(1)

From ginger, affects inflammatory and digestive processes, potentially influencing CBP β.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

A green tea compound, modulates kinase pathways, potentially influencing CBP β.

Allicin

539-86-6sc-202449
sc-202449A
1 mg
5 mg
$489.00
$1557.00
7
(1)

From garlic, affects metabolic and immune pathways, potentially impacting CBP β.

Ursolic Acid

77-52-1sc-200383
sc-200383A
50 mg
250 mg
$56.00
$180.00
8
(1)

Found in apple peels, modulates cell proliferation and apoptosis, potentially influencing CBP β.

Rosmarinic Acid

20283-92-5sc-202796
sc-202796A
10 mg
50 mg
$58.00
$109.00
4
(1)

From rosemary, affects cellular signaling and inflammation, potentially influencing CBP β.

Salidroside

10338-51-9sc-472942
50 mg
$360.00
1
(0)

From Rhodiola, modulates stress response pathways, potentially impacting CBP β.